Sanofi Voluntarily Recalls Zantac OTC Pending Tests For NDMA Contamination
BRIDGEWATER, N.J. — Sanofi-Aventis U.S. LLC on Oct. 18 announced a voluntary recall of its Zantac over-the-counter (OTC) heartburn drug due to possible contamination with N-nitrosodimethylamine (NDMA), a possible carcinogen....To view the full article, register now.
Already a subscriber? Click here to view full article